18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats

European Journal of Pharmacology

Volumn 537, Issue 1-3, 2006, Pages 94-98

  Glick, Stanley D ^a   Ramirez, Ruby L ^a   Livi, Jacklyn M ^a   Maisonneuve, Isabelle M ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Conotoxin AuIB; 18 Methoxycoronaridine; Drug addiction; Interpeduncular nucleus; Mecamylamine; Medial habenula; Morphine; Nicotine receptors

Indexed keywords

18 METHOXYCORONARIDINE; CONOTOXIN; MECAMYLAMINE; MORPHINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; FEMALE; HABENULA; INTERPEDUNCULAR NUCLEUS; NONHUMAN; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ANIMALS; BEHAVIOR, ADDICTIVE; CONOTOXINS; FEMALE; HABENULA; IBOGAINE; MECAMYLAMINE; MESENCEPHALON; MORPHINE; MORPHINE DEPENDENCE; NARCOTICS; NICOTINIC ANTAGONISTS; RATS; RATS, LONG-EVANS; RECEPTORS, NICOTINIC; SELF ADMINISTRATION; SUCROSE;

EID: 33646143992     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.03.045     Document Type: Article

References (33)

1. Blander A., and Wise R.A. Anatomical mapping of brain stimulation reward sites in the anterior hypothalamic area: special attention to the stria medullaris. Brain Res. 483 (1989) 12-16
2. Christoph G.R., Leonzio R.J., and Wilcox K.S. Stimulation of the lateral habenula inhibits dopamine-containing neurons in the substantia nigra and ventral tegmental area of the rat. J. Neurosci. 6 (1986) 613-619
3. Ellison G. Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula. Brain Res. Rev. 19 (1994) 223-239
4. Glick S.D., and Maisonneuve I.M. Development of novel medications for drug addiction: the legacy of an African shrub. Ann. N.Y. Acad. Sci. 909 (2000) 88-103
5. Glick S.D., Kuehne M.E., Maisonneuve I.M., Bandarage U.K., and Molinari H.H. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats. Brain Res. 719 (1996) 29-35
6. Glick S.D., Maisonneuve I.M., and Dickinson H.A. 18-MC reduces methamphetamine and nicotine self-administration in rats. NeuroReport 11 (2000) 2013-2015
7. Glick S.D., Maisonneuve I.M., and Szumlinski K.K. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of anti-addictive efficacy, toxicity and mechanisms of action. Ann. N.Y. Acad. Sci. 914 (2000) 369-387
8. Glick S.D., Maisonneuve I.M., Kitchen B.A., and Fleck M.W. Antagonism of α3β4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. Eur. J. Pharmacol. 438 (2002) 99-105
9. Glick S.D., Maisonneuve I.M., and Kitchen B.A. Modulation of nicotine self-administration in rats by combination therapy with agents blocking α3β4 nicotinic receptors. Eur. J. Pharmacol. 448 (2002) 185-191
10. Grady S.R., Meinerz N.M., Cao J., Reynolds A.M., Picciotto M.R., Changeux J.P., McIntosh J.M., Marks M.J., and Collins A.C. Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. J. Neurochem. 76 (2001) 258-268
11. Guide for the Care and Use of Laboratory Animals. Institute of Laboratory Animal Resources Commission on Life Sciences, National Research Council (1996), National Academy Press, Washington, D.C.
12. Klink R., de Kerchoved'Exaer A., Zoli M., and Changeux J.-P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci. 21 (2001) 1452-1463
13. Lena C., Changeux J.P., and Mulle C. Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J. Neurosci. 13 (1993) 2680-2688
14. Luo S.Q., Kulak J.M., Cartier G.E., Jacobsen R.B., Yoshikami D., Olivera B.M., and McIntosh J.M. Conotoxin AuIB selectively blocks α3β4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J. Neurosci. 18 (1998) 8571-8579
15. Maisonneuve I.M., and Glick S.D. Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine. Eur. J. Pharmacol. 383 (1999) 15-21
16. Maisonneuve I.M., Warner L.M., and Glick S.D. Biphasic dose-related effects of morphine on dopamine release. Drug Alcohol Depend. 65 (2001) 55-63
17. Margeta-Mitrovic M., Mitrovic I., Riley R.C., Jan L.Y., and Basbaum A.I. Immunohistochemical localization of GABA(B) receptors in the rat central nervous system. J. Comp. Neurol. 405 (1999) 299-321
18. Nishikawa T., Fage D., and Scatton B. Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat. Brain Res. 373 (1986) 324-336
19. Pace C.J., Glick S.D., Maisonneuve I.M., and Fleck M.W. Mechanism of inhibitory action of ibogaine and 18-MC at nicotinic acetylcholine receptors. Abstr. - Soc. Neurosci. 683 (2003) 2
20. Pace C.J., Glick S.D., Maisonneuve I.M., He L.W., Jokiel P.A., Kuehne M.E., and Fleck M.W. Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration. Eur. J. Pharmacol. 492 (2004) 159-167
21. Papke R.L., Sanberg P.R., and Shytle R.D. Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 297 (2001) 646-656
22. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. (1986), Academic Press Inc, San Diego, CA
23. Perry D.C., Xiao Y., Nguyen H.N., Musachio J.L., Davila-Garcia M.I., and Kellar K.J. Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography. J. Neurochem. 82 (2002) 468-481
24. Quick M.W., Ceballos R.M., Kasten M., McIntosh J.M., and Lester R.A.J. Á3β4 subunit-containing nicotinic receptors dominate function in rat medial habenula neurons. Neuropharmacology 38 (1999) 769-783
25. Rezvani A.H., Overstreet D.H., Yang Y., Maisonneuve I.M., Bandarage U.K., Kuehne M.E., and Glick S.D. Attenuation of alcohol consumption by a novel non-toxic ibogaine analog (18-methoxycoronaridine) in alcohol preferring rats. Pharmacol. Biochem. Behav. 58 (1997) 615-619
26. Rompre P.P., and Miliaressis E. Pontine and mesencephalic substrates of self-stimulation. Brain Res. 359 (1985) 246-259
27. Sutherland R.J. The dorsal diencephalic conduction system: a review of the anatomy and functions of the habenular complex. Neurosci. Biobehav. Rev. 6 (1982) 1-13
28. Sutherland R.J., and Nakajima S. Self-stimulation of the habenular complex in the rat. J. Comp. Physiol. Psychol. 95 (1981) 781-791
29. Szumlinski K.K., Maisonneuve I.M., and Glick S.D. The potential anti-addictive agent, 18-methoxycoronaridine (18-MC), blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment. Brain Res. 864 (2000) 13-23
30. Taraschenko O.D., Ramirez R.L., Livi J.M., Maisonneuve I.M., and Glick S.D. 18-MC acts in the medial habenula to attenuate opioid reward and mesolimbic dopamine sensitization to morphine. Abstr. - Soc. Neurosci. 801 (2005) 10
31. Vachon M.P., and Miliaressis E. Dorsal diencephalic self-stimulation: a movable electrode mapping study. Behav. Neurosci. 106 (1992) 981-991
32. Weeks J.R. Long-term intravenous infusion. In: Myers R.D. (Ed). Methods in Psychobiology vol. 2 (1972), Academic Press, New York 155-168
33. Wonnacott S. Presynaptic nicotinic ACh receptors. TINS 30 (1997) 92-98